Puma Biotechnology Q3 Adj. EPS $0.21 Beats $0.04 Estimate, Sales $54.500M Beat $51.000M Estimate
Benzinga Newsdesk 12 months ago
EarningsEarnings BeatsNews
Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.04 by 366.67 percent. This is a 53.33 percent decrease over earnings of $0.45 per share from
Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.04 by 366.67 percent. This is a 53.33 percent decrease over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $54.500 million which beat the analyst consensus estimate of $51.000 million by 6.86 percent. This is a 32.30 percent decrease over sales of $80.500 million the same period last year.